Boston Scientific Share Price Today
(NASDAQ: BSX)

Name: Boston Scientific Share Price Today (NASDAQ: BSX) - Boston Scientific Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Boston Scientific share price is $102.71 & ₹8,889.04 as on 30 Jan 2025, 2.30 'hrs' IST

$102.71

▲

0.39

(0.38%)

Market is closed - opens 8 PM, 30 Jan 2025

View live Boston Scientific share price in Dollar and Rupees. Guide to invest in Boston Scientific stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Boston Scientific, along with analyst recommendations, forecasts, and comprehensive financials.

Boston Scientific share price movements

Today's Low: $102.33
Today's High: $103.16
$102.71
0.37%
Downside
Day's Volatility :0.8%
Upside
0.43%
52 Weeks Low: $62.64
52 Weeks High: $103.17
$102.71
39.02%
Downside
52 Weeks Volatility :39.29%
Upside
0.45%

Boston Scientific (BSX) Returns

Period	Boston Scientific Corp.	Sector (Health Care)	S&P500
3 Months	22.24%	-1.7%	3.9%
6 Months	36.66%	-3.0%	11.1%
1 Year	62.36%	3.6%	22.6%
3 Years	139.42%	11.6%	36.3%

Boston Scientific (BSX) Key Statistics

in dollars & INR

Previous Close	$102.32
Open	$102.74
Today's High	$103.155
Today's Low	$102.33
Market Capitalization	$150.8B
Today's Volume	$4.3M
52 Week High	$103.17
52 Week Low	$62.635
Revenue TTM	$15.9B
EBITDA	$4.1B
Earnings Per Share (EPS)	$1.21
PE Ratio	84.56
Profit Margin	11.26%
Quarterly Earnings Growth YOY	-0.06%
Return On Equity TTM	8.92%

How to invest in Boston Scientific Stock (BSX) from India?

It is very easy for Indian residents to invest directly in Boston Scientific from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Boston Scientific stock in both Indian Rupees (INR) and US Dollars (USD). Search for Boston Scientific or BSX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Boston Scientific or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Boston Scientific shares which would translate to 0.008 fractional shares of Boston Scientific as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Boston Scientific, in just a few clicks!

Returns in Boston Scientific (BSX) for Indian investors in Rupees

The Boston Scientific stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Boston Scientific investment value today

Current value as on today

₹1,66,595

Returns

₹66,595

(+66.6%)

Returns from Boston Scientific Stock

₹62,362 (+62.36%)

Dollar Returns

₹4,233 (+4.23%)

Indian investors sentiment towards Boston Scientific (BSX)

80.85%

Period: Dec 30, 2025 to Jan 29, 2025. Change in 30 Days versus previous period

Investment in Boston Scientific Shares from India has grown by 80.85% over the past 30 days, indicating increased transactional activity.

215%

Period: Dec 30, 2025 to Jan 29, 2025. Change in 30 Days versus previous period

Search interest for Boston Scientific Stock from India on INDmoney has increased by 215% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Boston Scientific Stock (BSX Ticker)

Name	Shares Held	Change in Shares	% of Assets
Axis Growth Opportunities Fund Direct Growth	67052	-	0.36%
Axis Innovation Fund Direct Growth	8031	243.74	0.50%
Motilal Oswal S&P 500 Index Fund Direct Growth	12714	43.74	0.26%

Global Institutional Holdings in Boston Scientific

FMR Inc
9.17%
Vanguard Group Inc
8.91%
BlackRock Inc
8.73%
State Street Corp
4.26%
PRIMECAP Management Company
2.57%
Wellington Management Company LLP
2.23%

Analyst Recommendation on Boston Scientific

Buy

91%Buy

8%Hold

0%Sell

Based on 37 Wall street analysts offering stock ratings for Boston Scientific(by analysts ranked 0 to 5 stars)

Based on 37 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Boston Scientific Stock (BSX)

What analysts predicted

Downside of 0.55%

Target:

$102.15

Current:

$102.71

Insights on Boston Scientific Stock (Ticker Symbol: BSX)

Price Movement
In the last 1 month, BSX stock has moved up by 14.5%
Increasing Revenue
Boston Scientific Corp. has shown consistent growth in its revenue over the last five quarters, increasing from $3.52 billion to $4.20 billion. On average, the company has seen a revenue growth of 4.3% each quarter during this period.
Increasing Net Profit
Boston Scientific Corp. has shown positive profit trends over the last two quarters. The net profit increased from $324.0 million to $468.0 million, representing an average increase of 30.8% per quarter.

BSX Boston Scientific Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$9.8B	↑ 8.57%
Net Income	$1.7B	↑ 1506.73%
Net Profit Margin	17.01%	↑ 15.86%

	FY19	Y/Y Change
Revenue	$10.7B	↑ 9.28%
Net Income	$4.7B	↑ 181.27%
Net Profit Margin	43.78%	↑ 26.77%

	FY20	Y/Y Change
Revenue	$9.9B	↓ 7.66%
Net Income	$-140.0M	↓ 102.98%
Net Profit Margin	-1.41%	↓ 45.19%

	FY21	Y/Y Change
Revenue	$11.9B	↑ 19.92%
Net Income	$1.0B	↓ 843.57%
Net Profit Margin	8.76%	↑ 10.17%

	FY22	Y/Y Change
Revenue	$12.7B	↑ 6.68%
Net Income	$698.0M	↓ 32.95%
Net Profit Margin	5.5%	↓ 3.26%

	FY23	Y/Y Change
Revenue	$14.2B	↑ 12.29%
Net Income	$1.6B	↑ 128.22%
Net Profit Margin	11.19%	↑ 5.69%

	Q2 FY23	Q/Q Change
Revenue	$3.6B	↑ 6.2%
Net Income	$270.0M	↓ 14.01%
Net Profit Margin	7.5%	↓ 1.77%

	Q3 FY23	Q/Q Change
Revenue	$3.5B	↓ 2.0%
Net Income	$504.0M	↑ 86.67%
Net Profit Margin	14.29%	↑ 6.79%

	Q4 FY23	Q/Q Change
Revenue	$3.7B	↑ 5.61%
Net Income	$505.0M	↑ 0.2%
Net Profit Margin	13.56%	↓ 0.73%

	Q1 FY24	Q/Q Change
Revenue	$3.9B	↑ 3.52%
Net Income	$492.0M	↓ 2.57%
Net Profit Margin	12.76%	↓ 0.8%

	Q2 FY24	Q/Q Change
Revenue	$4.1B	↑ 6.85%
Net Income	$324.0M	↓ 34.15%
Net Profit Margin	7.86%	↓ 4.9%

	Q3 FY24	Q/Q Change
Revenue	$4.2B	↑ 2.16%
Net Income	$468.0M	↑ 44.44%
Net Profit Margin	11.12%	↑ 3.26%

	FY18	Y/Y Change
Profit	$6.9B	↑ 8.66%

	FY19	Y/Y Change
Profit	$7.6B	↑ 8.85%

	FY20	Y/Y Change
Profit	$6.4B	↓ 15.24%

	FY21	Y/Y Change
Profit	$8.1B	↑ 26.94%

	FY22	Y/Y Change
Profit	$8.7B	↑ 6.78%

	FY23	Y/Y Change
Profit	$9.9B	↑ 14.01%

	Q2 FY23	Q/Q Change
Profit	$2.5B	↑ 7.66%

	Q3 FY23	Q/Q Change
Profit	$2.4B	↓ 4.51%

	Q4 FY23	Q/Q Change
Profit	$2.6B	↑ 6.75%

	Q1 FY24	Q/Q Change
Profit	$2.6B	↑ 2.68%

	Q2 FY24	Q/Q Change
Profit	$2.6B	↓ 2.34%

	Q3 FY24	Q/Q Change
Profit	$2.9B	↑ 12.07%

	FY18	Y/Y Change
Operating Cash Flow	$310.0M	↓ 78.26%
Investing Cash Flow	$-1.9B	↑ 90.2%
Financing Cash Flow	$1.4B	↑ 1201.82%

	FY19	Y/Y Change
Operating Cash Flow	$1.8B	↑ 492.26%
Investing Cash Flow	$-5.0B	↑ 162.42%
Financing Cash Flow	$3.0B	↑ 107.61%

	FY20	Y/Y Change
Operating Cash Flow	$1.5B	↓ 17.86%
Investing Cash Flow	$-411.0M	↓ 91.85%
Financing Cash Flow	$293.0M	↓ 90.14%

	FY21	Y/Y Change
Operating Cash Flow	$1.9B	↑ 24.01%
Investing Cash Flow	$-1.6B	↑ 288.56%
Financing Cash Flow	$-95.0M	↓ 132.42%

	FY22	Y/Y Change
Operating Cash Flow	$1.5B	↓ 18.4%
Investing Cash Flow	$-2.0B	↑ 25.92%
Financing Cash Flow	$-548.0M	↑ 476.84%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$658.0M	↑ 246.32%
Investing Cash Flow	$-840.0M	↑ 73.55%
Financing Cash Flow	$43.0M	↓ 162.32%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$698.0M	↑ 6.08%
Investing Cash Flow	$-1.5B	↑ 81.07%
Financing Cash Flow	$16.0M	↓ 62.79%

Boston Scientific Technicals Summary

Sell

Neutral

Buy

Boston Scientific is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Boston Scientific (BSX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Boston Scientific Corp.	14.99%	36.66%	62.36%	139.42%	143.22%
Medtronic Plc	14.43%	13.57%	4.42%	-11.67%	-22.53%
Edwards Lifesciences Corp.	-3.92%	14.99%	-9.35%	-34.86%	-2.97%
Stryker Corporation	8.62%	17.38%	16.57%	57.66%	84.78%
Abbott Laboratories	13.04%	16.08%	13.0%	0.31%	46.86%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Boston Scientific Corp.	84.56	84.56	1.85	2.46	0.09	0.05	NA	14.05
Medtronic Plc	27.95	27.95	1.56	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	27.46	27.46	6.66	2.55	0.19	0.11	NA	16.18
Stryker Corporation	51.05	51.05	2.79	13.47	0.19	0.07	0.01	52.86
Abbott Laboratories	16.74	16.74	2.3	5.15	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Boston Scientific Corp.	Buy	$150.8B	143.22%	84.56	11.26%
Medtronic Plc	Buy	$117.2B	-22.53%	27.95	12.06%
Edwards Lifesciences Corp.	Buy	$42.0B	-2.97%	27.46	65.86%
Stryker Corporation	Buy	$150.6B	84.78%	51.05	16.34%
Abbott Laboratories	Buy	$221.8B	46.86%	16.74	13.99%

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Organization	Boston Scientific
Employees	48000
CEO	Mr. Michael F. Mahoney
Industry	Health Technology

Management People of Boston Scientific

Name	Title
Mr. Michael F. Mahoney	Chairman, President & CEO
Mr. Daniel J. Brennan CPA	Executive VP & CFO
Mr. Joseph M. Fitzgerald	Executive VP & Group President of Cardiology
Mr. Jeffrey B. Mirviss M.B.A.	Executive VP & President of Peripheral Interventions
Mr. Arthur Crosswell Butcher	Executive VP and Group President of MedSurg & Asia Pacific
Mr. John Bradley Sorenson	Executive Vice President of Global Operations
Ms. Emily Woodworth	Senior VP, Global Controller & Chief Accounting Officer
Ms. Jodi Euerle Eddy	Senior VP and Chief Information & Digital Officer
Mr. Jonathan R Monson	Senior VP of Investor Relations
Mr. Vance R. Brown	Senior VP, General Counsel & Corporate Secretary

Important FAQs about investing in BSX Stock from India :

What is Boston Scientific share price today?

Boston Scientific share price today stands at $102.71, Open: $102.74 ; Previous Close: $102.32 ; High: $103.16 ; Low: $102.33 ; 52 Week High: $103.17 ; 52 Week Low: $62.64.

The stock opens at $102.74, after a previous close of $102.32. The stock reached a daily high of $103.16 and a low of $102.33, with a 52-week high of $103.17 and a 52-week low of $62.64.

Can Indians buy Boston Scientific shares?

Yes, Indians can invest in the Boston Scientific (BSX) from India.

With INDmoney, you can buy Boston Scientific at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Boston Scientific at zero transaction cost.

How can I buy Boston Scientific shares from India?

It is very easy to buy Boston Scientific from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Boston Scientific (BSX) be purchased?

Yes, you can buy fractional shares of Boston Scientific with INDmoney app.

What are the documents required to start investing in Boston Scientific stocks?

To start investing in Boston Scientific, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.